The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
AITA names five-member Indian team for Davis Cup World Group 1 play-off away tie against Denmark
Sumit Nagal fought fire with fire to bring India back in the Davis Cup World Group Play-off tie against Denmark, winning the second singles.
The Indian Davis Cup team was relegated to the World Group II for the first time since the new format was launched in 2019 after losing the play-off tie 2-3 to Denmark.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances